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Background: Osteochondral defects significantly affect patients’ quality of life and represent challenging tissue
lesions, because of the poor regenerative capacity of cartilage. Tissue engineering has long sought to promote
cartilage repair, by employing artificial scaffolds to enhance cell capacity to deposit new cartilage. An ideal biomaterial
should closely mimic the natural environment of the tissue, to promote scaffold colonization, cell differentiation and
the maintenance of a differentiated cellular phenotype. The present study evaluated chitosan scaffolds enriched with
D-(+) raffinose in osteochondral defects in rabbits. Cartilage defects were created in distal femurs, both on the condyle
and on the trochlea, and were left untreated or received a chitosan scaffold. The animals were sacrificed after 2 or 4
weeks, and samples were analysed microscopically.
Results: The retrieved implants were surrounded by a fibrous capsule and contained a noticeable inflammatory
infiltrate. No hyaline cartilage was formed in the defects. Although defect closure reached approximately 100% in the
control group after 4 weeks, defects did not completely heal when filled with chitosan. In these samples, the lesion
contained granulation tissue at 2 weeks, which was then replaced by fibrous connective tissue by week 4. Noteworthy,
chitosan never appeared to be integrated in the surrounding cartilage.
Conclusions: In conclusion, the present study highlights the limits of D-(+) raffinose-enriched chitosan for cartilage
regeneration and offers useful information for further development of this material for tissue repair.
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Cartilage lesions represent a serious health concern
because of the poor regenerative capacity of this tissue
[1]. Cartilage damage leads to a natural repair process
which mostly consists in the formation of fibro-cartilage,
which lacks the strength and deformability characteris-
tics of hyaline cartilage, with a consequent loss of joint
functionality [2,3]. Tissue engineering approaches have
long been tested to promote cartilage repair, by employ-
ing artificial substrates that can be used as a scaffold for
cells, such as chondrocytes or autologous mesenchymal
cells, capable to deposit new extracellular matrix [4,5].
The choice of a biomaterial with adequate characteristics
is critical for clinical success [6], and an ideal biomaterial
should closely mimic the natural environment of the* Correspondence: francesca.ravanetti@unipr.it
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unless otherwise stated.tissue, to promote scaffold colonization, cell differenti-
ation and the maintenance of the differentiated pheno-
type [7].
Chitosan is considered a promising material for the
tissue engineering of articular cartilage [8,9] because of
its similarity to glycosaminoglycans, important compo-
nents of the extracellular matrix. Moreover, chitosan is
degraded in vivo by lysozyme [10] and it has been
hypothesized that catabolites from chitosan degradation
could be involved in the synthesis of chondroitin sulfate
and keratan. Consistently with this hypothesis, chitosan
injections into the articular cavity of rats significantly
increased chondrocyte density [11].
Chitosan properties can be affected by controlling the
molecular weight of the monomer, its degree of deacetyla-
tion and its calcium content, which makes chitosan a very
adaptable material to clinical requirements and needs [12].al. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Ravanetti et al. Journal of Negative Results in BioMedicine  (2015) 14:2 Page 2 of 10Bettini and colleagues showed that raffinose at high
concentrations makes the two-dimensional structure of
chitosan smoother, highly hydrophilic, and with excel-
lent elastic properties [13].
The purpose of the present study was to evaluate the
effect of chitosan scaffolds enriched with D-(+) raffinose
to promote the repair of cartilage defects in a rabbit model.Results
Subcutaneous implant
Histological examination of chitosan scaffolds inserted
into a sub cute pouch in the inter-scapular region,
showed that the material was properly positioned and
surrounded by a fibrous capsule (Figure 1a). This cap-
sule was homogeneous along the whole perimeter of the
material, with limited areas of necrosis and inflammatory
cells (Figure 1b).
The implant contained an inflammatory infiltrate com-
prising granulocytes, mostly neutrophils and eosinophils.
Karyolysis, pyknosis and karyorrhexis were also ob-
served. Noticeably, the number of fibroblasts infiltrating
the outer pores of the scaffold was low.Osteochondral defects
Osteochondral defects were macroscopically evaluated
by a 4-parameter assessment: joint functionality, defect
contour, cartilage erosion and cartilage appearance. A
final score was assigned by adding the scores for each
tested parameter (Table 1). As for the first parameter, no
animal showed signs of articular pain, indicating that the
graft material did not affect joint function. The margins
of the experimental defects were always clearly visible
regardless of the presence of chitosan, even 4 weeks after
surgery. As for cartilage erosion, cartilage was mostly
intact around the defect, with one exception, where a
little cartilage abrasion was observed around the troch-
lea in the presence of a chitosan implant. Almost all the
cartilage defects however appeared eroded and damaged,Figure 1 Subcutaneous chitosan scaffold after 2 weeks. Hematoxylin &
°fibrous capsule, + necrosis.both in the controls and in the chitosan-treated animals
at all experimental time-points.
After 2 and 4 weeks, almost all the condylar defects
appeared visually colourless and irregular, both in the con-
trol and in the chitosan-treated group (Figure 2). Note-
worthy, trochlear defects appeared matt in all animals, and
no observer found the presence of translucent, cartilage-
like tissue. No significant difference was found in the over-
all score between the groups (Figure 3), with the only
exception of the control trochlear implant at 4 weeks. The
score for this site was significantly higher than that of the
control trochlear at 2 weeks (p ≤ 0.05), control condyle at 4
weeks (p ≤ 0.01), control condyle at 2 weeks (p ≤ 0.001),
treated trochlea at 4 weeks (p ≤ 0.01), treated condyle at 4
weeks (p ≤ 0.01), treated condyle at 2W (p ≤ 0.01).
Scaffold porosity evaluation
Image analysis was used to assess the effects of scaffold
and implant site on wound healing. Although all the
scaffolds were placed inside the surgical defects, scaffold
deformation, resulting in oval or bilobate shapes, was
often observed, and this may have affected the contact
between the scaffold and surrounding tissue.
Scaffold porosity was evaluated by measuring pore area
(μm2) in the outer circumferential part of the chitosan
implant and in the inner portion (Figure 4). Outer pores
were significantly smaller than inner pores (Figure 5), both
in the pre-grafting scaffold (outer pore area M= 77.00 ±
58.97; area of the internal pores M = 205.80 ± 74.25) and
after grafting at both experimental time points. The outer
pore area was 51.15 ± 38.63, and the inner pore area was
215.67 ± 138.88 at 2 weeks, whereas the outer pore area
was 64.45 ± 31.89 and the inner pore area was 234.16 ±
143.10 at 4 weeks (p <0.01).
Histologic analysis of defects
Microscopic analysis was performed using the O’Driscoll
scoring test, to understand the quality of the newly
deposited tissue (Table 1).Eosin staining, magnification 10X (a) and 20X (b). Symbols: *scaffold,
Table 1 Data of the macroscopic score in the left side and data of O’Driscoll scoring system in the right side of the
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Figure 2 Macroscopic view of the osteochondral defects in the surgical controls (a,b) and chitosan-treated defects (c,d) after 2 weeks
(a,c) and 4 weeks (b,d). Symbols: arrows indicate trochlear defects; rounded arrowheads indicate condylar defects.
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Figure 3 Macroscopic evaluation of the osteochondral defects expressed as mean ± standard deviation. 2W (2 weeks), 4W (4 weeks). *
indicates statistical significance.
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formed in the osteochondral defects, but only a granula-
tion tissue and fibrous cartilage were observed. This
finding was confirmed by Masson staining, which
highlighted the absence of glycosaminoglycans typical of
hyaline cartilage. Defect closure reached approximately
100% in the control group after 4 weeks (Figure 6e, f ).
However, defects did not completely heal when filled
with chitosan. The newly formed tissue was localized
only in the most superficial part of the scaffolds and in the
gap that was created by scaffold deformation (Figure 6d).
Two weeks after surgery, the newly deposited tissue
appeared to be exclusively composed of granulation tissue
(Figure 6a), with numerous fibroblasts near the blood
vessels (Figure 6c). By 4 weeks the granulation tissue
started to be replaced by a fibrous connective tissue, both
in the condyle and in the trochlea. The interface betweenFigure 4 Microphotographs of pre-grafting chitosan scaffold with Hethe defect and the surrounding tissue appeared to possess
a more solid and compact structure in the control group
as compared to chitosan-treated defects. Chitosan did not
appear firmly anchored to the defect regardless of time
point and implant site, and the newly formed connective
tissue presented with only a scant and superficial bond
with the surrounding cartilage (Figure 6b).
The results from the O'Driscoll test are reported in
Figure 7. As for condyle defects, treated animals had a
lower score compared to controls at 2 weeks (p < 0.01)
and at 4 weeks (p < 0.001).
A lower score was also recorded in chitosan-treated
trochlear defects than in controls at 2 weeks of
treatment, and this trend was confirmed at 4 weeks
as well (p < 0.001). Treated defect score did not
significantly change over time for both condyle and
trochlea.matoxylin & Eosin staining. Magnification 10X (a) and 20X (b, c).
Figure 5 Scaffold porosity evaluation. Pore area is expressed as mean ± standard deviation (μm2). 2W (2 weeks), 4W (4 weeks), *indicate
statistical significance.
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A poorly organised fibrocartilage tissue was observed 2
weeks after surgery in control condylar defects with the
presence of only a small amount of birefringent collagen
fibers (Figure 8). Fibroblasts were also visible around
the defect. No birefringent collagen bundles were de-
tectable in the treated samples and cell arrangement
was not suggestive of any real cellular organization. As for
trochlear defects, collagen bundles were observed only in
the control group, but were absent in the chitosan-treated
defects. After 4 weeks, fibrocartilage tissue completely
filled the control defects, with well evident birefringent
collagen fibers within the newly formed tissue.
When chitosan was implanted in the defects, although
fibrocartilage was observed (Figure 8), it did not fill the
whole defect and still presented with a poorly organised
structure.Discussion
The present work focused on the possible use of D-(+)
raffinose-enriched chitosan for cartilage regeneration and
offers some insight on the use of this biopolymer as
scaffold in cartilage defects [6,8,12,14,15]. Histological
examination of D-(+) raffinose-enriched chitosan im-
planted into the sub cute indicated that the graft material
stimulated fibroblast proliferation, which created a fibrous
capsule around the material. An abundant inflammatory
infiltrate, mainly consisting of granulocytes, was observed
inside the chitosan mesh. The presence of these cells in
chitosan scaffolds has already been described and some
authors demonstrated a chemotactic effect by this material
on inflammatory cells [16-19]. Neutrophil migration
appears to be associated to specific interactions between
chitosan oligosaccharide and surface receptors on the
membrane of neutrophils, and to depend on chitosan
Figure 6 Histology microphotographs of the defects stained with Masson’s trichrome. Chitosan scaffold treated defects (a,b,c,d) after 2
weeks (a,c,d) and 4 weeks (b). Surgical controls after 4 weeks (e,f).
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undesired event, as increased inflammation has long been
associated to poor implant integration [21]. Moreover, the
presence of limited necrotic areas in the outermost layer
of the implanted material raises questions on the biocom-
patibility of chitosan modified with D-(+) raffinose. How-
ever, recent studies have shown that chitosan interactions
with the host’s immune system is complex and involves
the modulation of anti-inflammatory cell and cytokine
systems [22].
Strikingly, the macroscopic observation indicated that
the repair process was not affected by the presence of
chitosan and microscopic analysis confirmed that defect
healing was not complete in the presence of the scaffold.
The natural process of cartilage repair, as visible in the
surgical controls, involved the formation of fibrocarti-
lage, which does not possess comparable mechanical
properties to hyaline cartilage, and thus causes adecrease in joint function. The presence of scaffold rem-
nants inside the defects even after 4 weeks of healing
was not unexpected, as the chitosan used in this experi-
ment had a very high degree of deacetylation (92.8%),
which significantly affected its rate of resorption. This
finding is consistent with data reported in the literature,
and actually suggests that the greater the degree of
deacetylation of chitosan and the lower its resorption
rate [12].
Microscopic evaluation showed that the material did
not maintain its original cylindrical shape throughout
the experiment, but significant deformations were ob-
served. This created gaps, which reduced the scaffold-
tissue contact, and presumably the scaffold effectiveness
to promote tissue regeneration. It can be assumed that
this phenomenon was caused by the high deformability
of this material together with the surgical protocol used
in the study, and less deformable scaffolds will have to
Figure 7 Results of the microscopic analysis performed using the O’Driscoll scoring expressed as mean ± standard deviation. 2W (2
weeks), 4W (4 weeks), *indicates statistical significance.
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gaps, together with the different degree of porosity
found throughout the scaffold and the absence of
vascularization are the main obstacles to scaffold
colonization that emerged in this study. The different
degree of porosity observed between the outer material
and the inner part, may have affected the colonization of
the deeper areas of the scaffolds, because the reduced
average area of the outer pores may have prevented
cell migration into the scaffold. A work by Lien and
colleagues suggests that the optimal size of the pores is
closer to that found in the inner part the scaffolds [23].
Consistently with this phenomenon, microscopic ana-
lysis revealed the absence of vascular structures in chito-
san at both experimental time points, which arguably
represents a limiting factor for the colonization of theFigure 8 Microphotographs of histological sections at polarized light
(a) and chitosan treated defect (b).inner portion of the scaffolds, as this affected scaffold
perfusion and the supply of nutrients and oxygen [24].
Vessels however were abundant inside the granulation
tissue around the scaffold, as expected [8,12]. In fact it
seems that chitosan induced a transient vascularization
when implanted into cartilage [14,25].
The observed difference in scaffold porosity was not
caused by scaffold compression upon insertion in the
defect, as it was already present in pristine samples, and
it is most likely to be attributed to the synthesis proced-
ure. As a consequence, the preparation of the scaffolds
will have to be modified to allow for larger pores on the
outer surface.
Moreover, differences in the structure of the newly
formed tissue were observed when samples in the
presence or in the absence of mechanical loading were. Arrows indicate birefringent collagen bundles in surgical control
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thus providing an early, albeit non-functional structural
support, was observed in samples inserted in the condyles.
Polarized-light histology revealed that this was an areolar
connective tissue with a random distribution of collagen
bundles. When chitosan was inserted in the trochlea
however, a dense irregular connective tissue was depos-
ited. The higher density of the tissue was likely due to
a greater degree of internal structure of the tissue,
possibly because of the absence of a physiological load.
Consistently with this hypothesis, the polarized light
showed that the collagen bundles were mostly located
circumferentially around the defect.Conclusions
In conclusion, the present preliminary study offers some
useful information for further experiments aimed at
optimizing the performance of chitosan enriched with
D-(+) raffinose in cartilage repair, as it highlighted
several shortcomings of these scaffolds, which need to
be corrected to improve their performance. Changes in
material preparation can be envisaged to reduce its de-
formation thus increasing its contact with the surrounding
tissue and to promote cellular colonization by increas-
ing pore size in its outer portion. These scaffold could
also be loaded with autologous adult or mesenchymal
stem cells, or with growth or adhesion factors prior to
implantation [15,26] to enhance cell migration.Methods
Animals
Male New Zealand White rabbits (Harlan Laboratories,
Correzzana, Italy) were used for the study. The national
and European legislation regarding the protection of
animals used for experimental purposes (European Union
2010/63 – Health Ministry Authorization 16/04/2010)
was strictly followed in all experimental phases. Since
the amount of the effect due to the chitosan scaffold was
unknown, the present study can be considered as “pilot”
experience. The number of animals involved were
calculated on the basis of the ethical aspects imposed by
international and national regulations (European union
2010/63 – National DLgs 26/2014), which recommend
to minimize the number of individuals for experimental
trials and on the basis of the authors' experience with
this animal model.
The experimental plan (University of Parma Ethical
Committee approval 19/01/2007) involved the use of
seven male rabbits from same litters, weighing 4.2 ± 0.2 kg.
Animals were housed in separate cages, at a temperature of
20 ± 2°C, with a 12 hours light and 12 hours dark photo-
period, and were fed ad libitum with commercial pelleted
feed. Drinking water was administered ad libitum.Surgeries
The implant site was the femur distal epiphysis, which is
covered by articular cartilage. The rabbits underwent
surgeries a week after their arrival from the vendor.
Rabbits were anesthesized according to an approved
protocol (Domitor, Pfizer, 0.1 ml/kg; Ketavet 100,
Gellini, 0.3 ml/kg; Isoflurane-Vet, Mérial). The surgical
protocol included patellar arthrotomy with medial dis-
location of the patella to expose the articular surface of
the femur. Two osteochondral defects were created in
each femur, one on the medial condyle and the other on
the trochlea, respectively, to mimic loading and non
loading conditions. The osteochondral defects were
created with a low speed surgical drill, along the major
axis of the femur, under continuous irrigation with saline
solution. The defects had a diameter of 2.7 mm and a
depth of about 5 mm. The defects in the right segment
received chitosan scaffolds of 2.6 mm diameter and 5 mm
in length, while the defects on the left segment were left
untreated and served as control. The flap was repositioned
after implantation, the joint capsule and the soft tissues
were sutured (Assufil 3/0, Assut Sutures, Pully-Lausanne
Switzerland). A subcutaneous inter scapular pocket was
created for one animal, and a chitosan scaffold was
inserted. The skin was then sutured as described above.
The animals were randomly assigned to two groups con-
sisting of three animals each, for sacrifice at 2 and 4 weeks
(respectively 2W and 4W). All animals were subjected to a
complete clinical examination and orthopedic examin-
ation on a weekly basis, to assess the presence of swelling,
movement impairment, pain during passive movement
and limb functional recovery. The animal with the dorsal
sub cute implant underwent weekly clinic visits to assess
the presence of inflammation at the insertion site.
Sample collection and processing
The animals were sacrificed with i.p. injections (Tanax,
Roussel Hoechst Agrovet, 0.3 ml/kg) after general anesthesia
(Prequillan and Ketavet). The limbs were excised and
soft tissues were removed, to expose the knee joint and
allow for sample harvesting. The samples were fixed in
10% formaldehyde for 24 hours, washed in running
water and decalcified with an EDTA-based solution
(Microdec based EDTA, Diapath, Martinengo, Italy) for
72 hours. They were then dehydrated in alcohols at
increasing concentrations (Carlo Erba reagents), cleared
in xylene (Carlo Erba Reagents, Cornaredo, Italy) for
two hours and impregnated in liquid paraffin (Bio-plast
plus, Bio-Optica, Milan, Italy) for about two hours. The
procedure was performed with a tissue processor (ATP
700 Tissue Processor, Histo-line, Milan, Italy). At the
end of this procedure, the samples were embedded in
paraffin (Bio-plast plus, Bio-Optica) with a processor
(TBS88, Medite, Burgdorf, Germany) and perpendicular
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stained with hematoxylin-eosin to assess cellular distri-
bution and morphology. Samples from the osteochon-
dral defects were also stained with Masson's trichrome
staining (Kit, Bio-Opitca) (64), whereas sub cute samples
were also stained with Giemsa staining. Each sample was
evaluated by three different authors and scored as
described below.
Macroscopic defect evaluation
The knee joint was macroscopically evaluated after
exposure, using a validated scoring system [27]. The score
ranged from a minimum value equal to 0 and a maximum
value of 2. The test was modified because it was impos-
sible to assess the degree of intra-articular fibrosis. The
considered parameters were the degree of movement as
assessed by joint mobility, defect outline, whether the
margins were still distinguishable, cartilage erosion,
cartilage appearance, whether it appeared translucent,
as typical in hyaline cartilage, matte or colourless and
irregular, as in fibrocartilage.
Histological analysis
The histological analysis (with O’Driscoll scoring systems)
and the acquisition of images in polarized light, have been
carried out by means of a motorized microscope (Eclipse
90i, Nikon, Tokyo, Japan), equipped with a digital camera
(Nikon model DS-5M) and equipped with image analyzer
(NIS-Advanced Reserarch 2.1, Nikon).
Microscopic evaluation
The microscopic analysis was carried out using O'Driscoll
scoring system [28], modified using Masson's trichrome
staining. The parameters taken into consideration were
the predominant nature of the neo-formed tissue, whether
hyaline cartilage, cartilage or undifferentiated tissue,
fibrous tissue or bone. Furthermore, cellularity and
structural characteristics such as surface regularity,
structural integrity, the percentage of defect closure and
the union with the adjacent tissue, were considered.
Scaffold analysis
Porosity analysis was carried out with an image analyzer
(NIS-Advanced Reasearch 3.1, Nikon). For analysis
purposes, the scaffold was divided into an outer and
an inner circumferential portion. Pore area, expressed
in μm2, was measured both pregrafting and after graft-
ing at both experimental time points (2W and 4W).
Statistical analysis
Data were analyzed using statistical software SPSS 18
(SPSS inc., IBM) and reported in Table 1. For the macro-
scopic and microscopic scoring system the Kruskal-Wallis
analysis followed by a post-hoc Mann–Whitney pairwisecomparison test was used. 95% confidence intervals of
estimated differences between means were calculated for
each comparison. For the scaffold porosity the analysis of
variance ( ANOVA) followed by post test (Tukey, Scheffe)
was used. Results were considered statistically significant
when p < 0.05.
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